Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients

Marcus Inyama Asuquo, View ORCID ProfileEmmanuel Effa, View ORCID ProfileAkaninyene Otu, View ORCID ProfileOkokon Ita, Ubong Udoh, View ORCID ProfileVictor Umoh, View ORCID ProfileOluwabukola Gbotosho, View ORCID ProfileAnthonia Ikpeme, View ORCID ProfileSoter Ameh, William Egbe, Margaret Etok, View ORCID ProfileJochen Guck, View ORCID ProfileAndrew Ekpenyong
doi: https://doi.org/10.1101/2020.07.02.20145441
Marcus Inyama Asuquo
1Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria
2Joseph Ukpo Hospitals and Research Institutes (JUHRI), Afua Site, Ibiono Ibom, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: markaniekan@gmail.com
Emmanuel Effa
1Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria
2Joseph Ukpo Hospitals and Research Institutes (JUHRI), Afua Site, Ibiono Ibom, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emmanuel Effa
Akaninyene Otu
1Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria
2Joseph Ukpo Hospitals and Research Institutes (JUHRI), Afua Site, Ibiono Ibom, Nigeria
3Department of Infection and Travel Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Akaninyene Otu
Okokon Ita
1Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Okokon Ita
Ubong Udoh
1Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Umoh
2Joseph Ukpo Hospitals and Research Institutes (JUHRI), Afua Site, Ibiono Ibom, Nigeria
4Department of Internal Medicine, College of Health Sciences, University of Uyo, Uyo, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Victor Umoh
Oluwabukola Gbotosho
5Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 45229, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oluwabukola Gbotosho
Anthonia Ikpeme
1Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria
2Joseph Ukpo Hospitals and Research Institutes (JUHRI), Afua Site, Ibiono Ibom, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthonia Ikpeme
Soter Ameh
6Biostatistics Unit, Department of Community Medicine, University of Calabar, Calabar, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Soter Ameh
William Egbe
1Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria
2Joseph Ukpo Hospitals and Research Institutes (JUHRI), Afua Site, Ibiono Ibom, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Etok
2Joseph Ukpo Hospitals and Research Institutes (JUHRI), Afua Site, Ibiono Ibom, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jochen Guck
7Max-Planck-Zentrum für Physik und Medizin, Staudtstr. 2, 91058 Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jochen Guck
Andrew Ekpenyong
2Joseph Ukpo Hospitals and Research Institutes (JUHRI), Afua Site, Ibiono Ibom, Nigeria
8Department of Physics, Creighton University, Omaha, NE, 68178, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Ekpenyong
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The coronavirus disease 2019 (COVID-19) is now a pandemic with devastating social and economic consequences. The extent of the spread of COVID-19 within populations is uncertain since diagnostic tests have not been carried out on all eligible persons and doing such diagnostic tests on everyone is much less feasible in developing countries such as Nigeria. Tests for antibodies to SARS-CoV-2, the virus that causes COVID-19, are more affordable, readily available, and require minimal training than current diagnostic tests. Employing a seroepidemiological strategy, serological tests were conducted on 66 volunteering staff and patients at the University of Calabar Teaching Hospital (UCTH), a Federal Government owned tertiary healthcare facility, to determine the extent of exposure to SARS-CoV-2, from 17th to 25th June 2020. Using a COVID-19 IgG/IgM Rapid Test Cassette with emergency use authorization (EUA) from the Food and Drug Administration (FDA) of the United States, it was observed that of the 66 samples tested, 5 (7.6%) were both IgG and IgM positive and 17 (26%) were IgG positive. Moreover, for 44 of the 66 participants, simultaneous tests were carried out using a rapid test kit from a different manufacturer but without FDA-EUA and all the results completely matched with the FDA-EUA kit, except one case where the FDA-EUA kit showed positive for both IgG and IgM while the other kit was positive only for IgM. The 26% positive IgG indicates a high exposure rate for the hospital staff and patients and points to community transmission where the facility is situated. Hence, immediate activation of WHO guidelines for controlling community transmission is called for. These results can further serve as a pilot study to guide public health policies in response to COVID-19 pandemic in both the general population and in healthcare settings.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors received no external funding for this work. However, the Joseph Ukpo Hospitals and Research Institutes, JUHRI, provided partial funding from donations made through Friends of JUHRI, a 501(c)3 non-profit organization and public charity. JUHRI provides 100% free healthcare to the rural poor in Akwa Ibom and Cross River States of Nigeria.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study received ethical approval (UCTH/HREC/33/703) from the University of Calabar Teaching Hospital Health Research Ethics Committee.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred to in the paper is available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 24, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients
Marcus Inyama Asuquo, Emmanuel Effa, Akaninyene Otu, Okokon Ita, Ubong Udoh, Victor Umoh, Oluwabukola Gbotosho, Anthonia Ikpeme, Soter Ameh, William Egbe, Margaret Etok, Jochen Guck, Andrew Ekpenyong
medRxiv 2020.07.02.20145441; doi: https://doi.org/10.1101/2020.07.02.20145441
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients
Marcus Inyama Asuquo, Emmanuel Effa, Akaninyene Otu, Okokon Ita, Ubong Udoh, Victor Umoh, Oluwabukola Gbotosho, Anthonia Ikpeme, Soter Ameh, William Egbe, Margaret Etok, Jochen Guck, Andrew Ekpenyong
medRxiv 2020.07.02.20145441; doi: https://doi.org/10.1101/2020.07.02.20145441

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (214)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1090)
  • Dentistry and Oral Medicine (194)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
  • Epidemiology (9746)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2298)
  • Geriatric Medicine (221)
  • Health Economics (461)
  • Health Informatics (1548)
  • Health Policy (729)
  • Health Systems and Quality Improvement (600)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11618)
  • Intensive Care and Critical Care Medicine (615)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2136)
  • Nursing (133)
  • Nutrition (332)
  • Obstetrics and Gynecology (424)
  • Occupational and Environmental Health (516)
  • Oncology (1171)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (144)
  • Palliative Medicine (50)
  • Pathology (308)
  • Pediatrics (692)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2168)
  • Public and Global Health (4640)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (450)
  • Respiratory Medicine (621)
  • Rheumatology (273)
  • Sexual and Reproductive Health (224)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (42)
  • Transplantation (120)
  • Urology (94)